Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 4105-38-8
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15 days
Payment Terms: T/T, L/C, D/A, Western Union
Supply Ability: TON
CAS NO:: |
4105-38-8 |
Appearance:: |
White Or Off-white Crystalline Powder |
Molecular Formula:: |
C15H18N2O9 |
Molecular Weight:: |
370.31100 |
EINECS NO:: |
223-881-5 |
MDL NO:: |
NA |
CAS NO:: |
4105-38-8 |
Appearance:: |
White Or Off-white Crystalline Powder |
Molecular Formula:: |
C15H18N2O9 |
Molecular Weight:: |
370.31100 |
EINECS NO:: |
223-881-5 |
MDL NO:: |
NA |
Product Description:
Product Name: 2',3',5'-Tri-O-acetyluridine CAS NO: 4105-38-8
Synonyms:
O2',O3',O5'-triacetyl-uridine;
Uridine, 2‘,3‘,5‘-triacetate;
2`,3`,5`-Triacetyluridine;
Chemical & Physical Properties:
Appearance: White or off-white crystalline powder
Assay :≥99.0%
Density: 1.43g/cm3
Melting Point: 124-134℃
Refractive Index: 1.552
Storage Condition: -20℃
PKa: 9.39±0.10 (Predicted)
Safety Information:
Safety Statements: S24/25
WGK Germany: 3
HS Code: 29349990
2’,3’,5’-Triacetyluridine is used in the treatment of Alzheimer’s disease in mice and provide neuroprotective effects. Shown to also decrease depressive symptoms and increases in brain pH bipolar patients. Uridine triacetate is an orally available pro-drug of uridine approved by the FDA for the treatment of the rare autosomal recessive disorder called hereditary orotic aciduria. The drug was also approved for treating overdose of two chemotherapies (fluorouracil and capecitabine). Uridine triacetate was developed by Wellstat Therapeutics and licensed to BTG.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
